1Dellinger R P, Cadet J M, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock[J]. Intensive Care Meal,2005, 30 (4): 536.
2Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of se- vere sepsis in the United States : analysis of incidence, outcome,and associated costs of care[J]. Crit Care Med,2001,29(10) : 1303-1310.
3Luzzani A,Polati E,Dorizzi R,et al. Comparison of procalcitoninand C-reactive protein as markers of sepsis[J]. Crit Care Med,2003,31 (6) : 1737-1741.
4Kocabas E, Sarikcioglu A. C-react iveprotein, interleukin-6, i nter- leukin-8 and tumor necrosis factoral phainthe diagnosis of nenatal sepsis[J]. Turk J Ped iatr,2007,49 ( 1 ) :7-20.
5Caini S ,Koldkjaer OG, Pederson C, et al. Procalcitonin ,hpopo-lysac- charide-binding protein,interleukin-6and C-reactive proteinin com- munity-acquired infections and sepsis: a prospective study[J ]. Crit Care, 2006,10(2) : R53.
6Vindenes H, Ulves t acl E, Bierknes R. Ncreased levels of circul at ing interleukin 8 in patient s with large burn : relat ion t o burn size and sepsis[J]. J Trauma. 1995, 39(5) : 635- 640.
7Sibbald W J, Vincent J L. Round table conference on clinical thsis for the treatment of sepsis[ J] . Crit Care Med, 1997, 25 (2) : 394.
8Claeys R, Vinken S, Spapen H, et al . Plasma procalcit onin and C - reactive protein in acute septic shock : clinical and bio- logical corerlates[J] . Crit Care Med, 2002, 30(4) : 757 - 762.
9Kocabas E Sarikcioglu A. C - react iveprotein interleukin - 6 in- terleukin -8 and tumor necrosis factoral phainthe diagnosis of neonatal sepsis[ J]. Turk J Pediatr, 2007,49 ( 1 ) :7 - 20.
